Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Intestinal bacteria can metabolize unabsorbed polyphenols (plant compounds) to produce smaller molecules which may impact health. In addition, evidence suggests that this process may be affected by body fatness. This study aims to investigate absorption of blackberry polyphenols, their impact on intestinal bacteria, polyphenol metabolites formed by intestinal bacteria, and how these processes differ for obese and lean individuals. It is hypothesized that polyphenol absorption and metabolism will differ between obese and lean individuals and that differences in intestinal microbiota may play a role.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control-Blackberry | Experimental | Participants will receive a controlled diet with the control food (jello) first and then cross over to the controlled diet with blackberries. |
|
| Blackberry-Control | Experimental | Participants will receive a controlled diet with blackberries first and then cross over to the controlled diet with the control food (jello). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blackberries | Other | Participants will receive blackberries as part of a controlled diet. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in fecal microbiota | Feces will be analyzed for bacterial typing at 0 and 4 weeks of each diet period. | 0 weeks, 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in blackberry nutrients & metabolites | 0, 30, 60, 90, 120, 150, 180, 240, 300, 360, and 420 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Change in gene expression | Gene expression in whole blood will be evaluated at the beginning and end of each diet period, through global gene expression using the Affymetrix platform. Changes in specific genes observed with global gene expression technology will be confirmed through RT-PCR. | 0 weeks, 4 weeks |
| Change in metabolomics |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Janet A Novotny, Ph.D. | USDA Beltsville Human Nutrition Research Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beltsville Human Nutrition Research Center | Beltsville | Maryland | 20906 | United States |
Not provided
| ID | Term |
|---|---|
| D024821 | Metabolic Syndrome |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Control | Other | Participants will receive a control food (jello) as part of a controlled diet. |
|
Blood, urine, and feces will be analyzed by a technique called metabolomics, which is a broad sampling of metabolites. |
| 0 weeks, 4 weeks |
| Change in biomarkers of cancer | Biomarkers of cancer risk such as oxidative stress and inflammatory markers will be analyzed at the beginning and end of each diet period. | 0 weeks, 4 weeks |
| Change in lipopolysaccharide | Lipopolysaccharide will be measured in the blood as a measure of gut leakiness. | 0 weeks, 4 weeks |
| D009750 |
| Nutritional and Metabolic Diseases |